Skip to main
ALHC

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 45%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc is well-positioned to leverage the anticipated 2026 Medicare Advantage rate update, which is expected to favorably impact its financial performance as competitors reduce benefits. The company's integrated Medicare Advantage-Value-Based Care model is projected to facilitate long-term market share expansion and accelerate growth rates. Additionally, gross profit per member per month (PMPM) for initial cohorts is expected to increase from the range of $90-$150 to over $230 in subsequent years, highlighting the potential for significant profitability improvements as membership grows and margins mature.

Bears say

The financial outlook for Alignment Healthcare Inc. appears negative due to challenges related to its value-based care model, which faces data friction across different payors and inconsistency in results from employed or affiliated primary care providers. Despite achieving reduced Average Daily Census (ADK) metrics during a period of higher healthcare utilization, the overall market context and operational hurdles may impact long-term performance. Additionally, the company's valuation multiple is slightly above that of its peer managed care organizations, suggesting potential overvaluation given the operational risks and competitive pressures in the healthcare sector.

Alignment Healthcare (ALHC) has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 45% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 11 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Jan 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.